108 related articles for article (PubMed ID: 11180876)
1. Tumor angiogenesis as a prognostic predictor in pancreatic cancer.
Karademir S; Sökmen S; Terzi C; Sağol O; Ozer E; Astarcioğlu H; Coker A; Astarcioğlu I
J Hepatobiliary Pancreat Surg; 2000; 7(5):489-95. PubMed ID: 11180876
[TBL] [Abstract][Full Text] [Related]
2. Angiogenesis and p53 and H-ras mutations in pancreatic ductal adenocarcinoma.
Ozer E; Ozkal S; Karademir S; Sağol O; Sökmen S; Coker A; Küpelioğlu A; Astarcioğlu I
Anal Quant Cytol Histol; 1999 Dec; 21(6):473-6. PubMed ID: 10626015
[TBL] [Abstract][Full Text] [Related]
3. Angiogenesis in pancreatic carcinoma: thymidine phosphorylase expression in stromal cells and intratumoral microvessel density as independent predictors of overall and relapse-free survival.
Fujioka S; Yoshida K; Yanagisawa S; Kawakami M; Aoki T; Yamazaki Y
Cancer; 2001 Oct; 92(7):1788-97. PubMed ID: 11745251
[TBL] [Abstract][Full Text] [Related]
4. Prognostic role of angiogenesis and its correlations with thymidine phosphorylase and p53 expression in ductal adenocarcinoma of the pancreas.
Jinfeng M; Kimura W; Sakurai F; Moriya T; Mizutani M; Hirai I
Hepatogastroenterology; 2007 Sep; 54(78):1635-40. PubMed ID: 18019682
[TBL] [Abstract][Full Text] [Related]
5. Angiogenesis and cathepsin expression are prognostic factors in pancreatic adenocarcinoma after curative resection.
Niedergethmann M; Hildenbrand R; Wolf G; Verbeke CS; Richter A; Post S
Int J Pancreatol; 2000 Aug; 28(1):31-9. PubMed ID: 11185708
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of microvessel density and p53 expression in pancreatic adenocarcinoma.
Jureidini R; da Cunha JE; Takeda F; Namur GN; Ribeiro TC; Patzina R; Figueira ER; Ribeiro U; Bacchella T; Cecconello I
Clinics (Sao Paulo); 2016 Jul; 71(6):315-9. PubMed ID: 27438564
[TBL] [Abstract][Full Text] [Related]
7. Vascular proliferation is associated with survival in pancreatic ductal adenocarcinoma.
Hoem D; Straume O; Immervoll H; Akslen LA; Molven A
APMIS; 2013 Nov; 121(11):1037-46. PubMed ID: 23489215
[TBL] [Abstract][Full Text] [Related]
8. Genetic alterations of K-ras, p53, c-erbB-2, and DPC4 in pancreatic ductal adenocarcinoma and their correlation with patient survival.
Shin SH; Kim SC; Hong SM; Kim YH; Song KB; Park KM; Lee YJ
Pancreas; 2013 Mar; 42(2):216-22. PubMed ID: 23344532
[TBL] [Abstract][Full Text] [Related]
9. Angiogenesis in adenocarcinoma of the uterine cervix.
Kaku T; Hirakawa T; Kamura T; Amada S; Kinukawa N; Kobayashi H; Sakai K; Ariyoshi K; Sonoda K; Nakano H
Cancer; 1998 Oct; 83(7):1384-90. PubMed ID: 9762940
[TBL] [Abstract][Full Text] [Related]
10. VEGF and Id-1 in pancreatic adenocarcinoma: prognostic significance and impact on angiogenesis.
Georgiadou D; Sergentanis TN; Sakellariou S; Filippakis GM; Zagouri F; Vlachodimitropoulos D; Psaltopoulou T; Lazaris AC; Patsouris E; Zografos GC
Eur J Surg Oncol; 2014 Oct; 40(10):1331-7. PubMed ID: 24480377
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of angiogenesis and Ki-67, p53, and p21 expression: a population-based endometrial carcinoma study.
Salvesen HB; Iversen OE; Akslen LA
J Clin Oncol; 1999 May; 17(5):1382-90. PubMed ID: 10334522
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of p53, Ki-67, VEGF and Glut-1 in resected stage I adenocarcinoma of the lung.
Minami K; Saito Y; Imamura H; Okamura A
Lung Cancer; 2002 Oct; 38(1):51-7. PubMed ID: 12367793
[TBL] [Abstract][Full Text] [Related]
13. Angiogenesis as a prognostic indicator in pancreatic ductal adenocarcinoma.
Stipa F; Lucandri G; Limiti MR; Bartolucci P; Cavallini M; Di Carlo V; D'Amato A; Ribotta G; Stipa S
Anticancer Res; 2002; 22(1A):445-9. PubMed ID: 12017330
[TBL] [Abstract][Full Text] [Related]
14. Morphometric microvascular characteristics in the prognosis of pancreatic and ampullary carcinoma.
Giannopoulos G; Kavantzas N; Parasi A; Tiniakos D; Peros G; Tzanakis N; Patsouris E; Pavlakis K
Pancreas; 2007 Jul; 35(1):47-52. PubMed ID: 17575545
[TBL] [Abstract][Full Text] [Related]
15. Microvessel Landscape Assessment in Pancreatic Ductal Adenocarcinoma: Unclear Value of Targeting Endoglin (CD105) as Prognostic Factor of Clinical Outcome.
Lytras D; Leontara V; Kefala M; Foukas PG; Giannakou N; Pouliakis A; Dervenis C; Panayiotides IG; Karakitsos P
Pancreas; 2015 Jan; 44(1):87-92. PubMed ID: 25058886
[TBL] [Abstract][Full Text] [Related]
16. Clinical contribution of bcl-2, p53 and Ki-67 proteins in pancreatic ductal adenocarcinoma.
Mäkinen K; Hakala T; Lipponen P; Alhava E; Eskelinen M
Anticancer Res; 1998; 18(1B):615-8. PubMed ID: 9568186
[TBL] [Abstract][Full Text] [Related]
17. The novel tumor angiogenic factor, adrenomedullin-2, predicts survival in pancreatic adenocarcinoma.
Hollander LL; Guo X; Salem RR; Cha CH
J Surg Res; 2015 Aug; 197(2):219-24. PubMed ID: 25982376
[TBL] [Abstract][Full Text] [Related]
18. Serum vascular endothelial growth factor/soluble vascular endothelial growth factor receptor 1 ratio is an independent prognostic marker in pancreatic cancer.
Chang YT; Chang MC; Wei SC; Tien YW; Hsu C; Liang PC; Tsao PN; Jan IS; Wong JM
Pancreas; 2008 Aug; 37(2):145-50. PubMed ID: 18665074
[TBL] [Abstract][Full Text] [Related]
19. Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma.
Axelsson K; Ljung BM; Moore DH; Thor AD; Chew KL; Edgerton SM; Smith HS; Mayall BH
J Natl Cancer Inst; 1995 Jul; 87(13):997-1008. PubMed ID: 7543156
[TBL] [Abstract][Full Text] [Related]
20. Tumor angiogenesis in chronic pancreatitis and pancreatic adenocarcinoma: impact of K-ras mutations.
Banerjee SK; Zoubine MN; Mullick M; Weston AP; Cherian R; Campbell DR
Pancreas; 2000 Apr; 20(3):248-55. PubMed ID: 10766450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
